The family of a woman who died from fungal meningitis is shocked that the pharmacy linked to the outbreak isn't regulated. Lilian Cary received a steroid injection in August that came from the New England Compounding Center. She passed away two weeks ago.
Her husband George is awaiting test results to see if he also has the illness. The couple went to the same pain treatment center in Michigan.
"This should not have happened. This is a tragedy that goes beyond our family," said her husband in regards to more than 100 sick with meningitis and the 12 who died.
137 people are battling a rare, noncontagious form of meningitis, up from 119 cases yesterday. The death toll remains at 12.
Tonight on the program Anderson will talk with the husband and daughter of Lilian Cary, 67, who died after receiving a potentially contaminated steroid injection linked to the outbreak. A memorial was held in her honor yesterday in Howell, Michigan where the family lives.
Cary's husband, George, is awaiting test results to see if he too has fungal meningitis. He also received a potentially tainted steroid injection, a common treatment for back pain, a few weeks after his wife.
Mr. Cary will share what he's faced these past few weeks. "Where are the politicians?" he asks. Cary is calling for more oversight of compounding pharmacies that make and sell medications across America. The New England Compounding Center (NECC) that made the steroid linked to the meningitis outbreak has recalled the drug and shut down its operations as the FDA, CDC and Massachusetts officials investigate the facility.
Anderson will also talk with Cary's daughter, Heather Andrus. She tells us she recently moved near her parents so her two children, an 8-year-old and 10-month old, could live closer to their grandmother. Now they are all mourning her loss.
No one at the pharmacy linked to the meningitis outbreak would even talk to Dr. Sanjy Gupta, but what he saw behind that Massachusetts facility is raising new questions. Elizabeth Cohen reports on the lack of federal guidelines and regulations for compounding companies. We're Keeping Them Honest.
Questions or comments? Send an email
Want to know more? Go behind the scenes with